BiondVax Pharmaceuticals Ltd. - stock earnings
Stock symbol BVXV is outdated, potentially delisted? Maybe it is available on other exchange?
BVXV Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2022Q3 | 3.7 million USD | ? USD |
| 2022Q2 | -12.9 million USD | ? USD |
| 2022Q1 | -9.4 million USD | ? USD |
| 2021Q4 | -10.8 million USD | ? USD |
| 2021Q3 | -9.0 million ILS | ? ILS |
| 2021Q2 | -12.0 million ILS | ? ILS |
| 2021Q1 | -8.2 million ILS | ? ILS |
| 2020Q4 | -14.1 million ILS | ? ILS |
| 2020Q3 | 55.3 million ILS | ? ILS |
| 2020Q2 | -42.0 million ILS | ? ILS |
| 2020Q1 | -3.7 million ILS | ? ILS |
| 2019Q4 | -43.0 million ILS | ? ILS |
BVXV Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2022 | -5.8 million USD | ? USD |
| 2021 | -40.0 million USD | ? USD |
| 2020 | -4.5 million USD | ? USD |
| 2019 | -109.2 million USD | ? USD |
| 2018 | -87.7 million USD | ? USD |
| 2017 | -34.6 million ILS | ? ILS |
| 2016 | -9.2 million ILS | ? ILS |
BVXV
Price: $1.36
52 week price:
Earnings Per Share: -2.55 USD
P/E Ratio: -0.95
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 88400
Ebitda: 416918Market Capitalization: 6.3 million